Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
Journal: The New England journal of medicine
Published: September 25, 2024
Effect of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intravenous Rivipansel.
Journal: Clinical pharmacology in drug development
Published: November 12, 2019
First prospective comparison of genotypic versus phenotypic tropism assays in predicting virologic responses to maraviroc in a phase 3 study.
Journal: The new microbiologica
Published: April 30, 2019
No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV-1-Infected Subjects.
Journal: Journal of clinical pharmacology
Published: June 20, 2018
Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1.
Journal: The Pediatric infectious disease journal
Published: October 13, 2017
First prospective comparison of genotypic vs phenotypic tropism assays in predicting virologic responses to Maraviroc (MVC) in a phase 3 study: MODERN.
Journal: Journal of the International AIDS Society
Published: November 14, 2014
The effects of boceprevir and telaprevir on the pharmacokinetics of maraviroc: an open-label, fixed-sequence study in healthy volunteers.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: December 19, 2013
Pharmacokinetic interaction between maraviroc and fosamprenavir-ritonavir: an open-label, fixed-sequence study in healthy subjects.
Journal: Antimicrobial agents and chemotherapy
Published: October 02, 2013
Safety and pharmacokinetics of nelfinavir during the second and third trimesters of pregnancy and postpartum.
Journal: HIV clinical trials
Published: February 07, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026